1Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
2National Biobank of Thailand, National Science and Technology Development Agency, Pathum Thani, Thailand.
Am J Trop Med Hyg. 2020 Jul;103(1):175-182. doi: 10.4269/ajtmh.19-0817. Epub 2020 May 7.
Chronic hepatitis C virus (HCV) infection can lead to liver cirrhosis and hepatocellular carcinoma. To eliminate HCV infection in an endemic area, an epidemiological baseline of the current HCV infection in the population is required. We therefore aimed to evaluate the HCV burden in the Thai Province of Phetchabun, which has the highest HCV infection rate in the country. Toward this, a province-wide district-based representative sampling of 4,769 individuals ages 35-64 years previously shown to represent high-risk age-groups were tested for anti-HCV antibodies using the automated chemiluminescent microparticle assays. Active HCV infection and subsequent genotyping were determined from serologically reactive samples by amplification of the HCV core gene. We found that 6.9% (327/4,769) were anti-HCV positive, of which 75.8% (248/327) had detectable HCV RNA and 5.8% (19/327) were in the presence of hepatitis B virus coinfection. Nucleotide sequencing and phylogenetic analysis revealed that HCV genotype 6 was the most prevalent (41%, 101/248), followed by genotype 3 (31%, 78/248), and genotype 1 (28%, 69/248). Socioeconomic and demographic factors including male gender, education, and agricultural work were associated with HCV seropositivity. From these results, we defined the regional HCV genotypes and estimated the HCV burden necessary toward the implementation of pan-genotypic direct-acting antivirals, which may be appropriate and effective toward the diversity of genotypes identified in this study. Micro-elimination of HCV in Phetchabun may serve as a model for a more comprehensive coverage of HCV treatment in Thailand.
慢性丙型肝炎病毒(HCV)感染可导致肝硬化和肝细胞癌。为了在流行地区消除 HCV 感染,需要对当前人群中 HCV 感染的流行情况进行流行病学基线调查。因此,我们旨在评估泰国碧差汶府的 HCV 负担,该府的 HCV 感染率是全国最高的。为此,我们对该省 35-64 岁的 4769 名具有代表性的人群进行了基于区县级的抽样检测,采用自动化化学发光微粒子免疫分析检测抗 HCV 抗体。从血清学反应性样本中通过 HCV 核心基因扩增确定活性 HCV 感染和随后的基因分型。我们发现,6.9%(327/4769)的人抗 HCV 阳性,其中 75.8%(248/327)的人 HCV RNA 可检测到,5.8%(19/327)的人同时感染乙型肝炎病毒。核苷酸测序和系统发育分析显示,HCV 基因型 6 最为流行(41%,101/248),其次是基因型 3(31%,78/248)和基因型 1(28%,69/248)。包括性别、教育程度和农业工作在内的社会经济和人口统计学因素与 HCV 血清阳性相关。根据这些结果,我们确定了该地区的 HCV 基因型,并估计了实施泛基因型直接作用抗病毒药物所需的 HCV 负担,这可能对本研究中鉴定的多种基因型是合适和有效的。在碧差汶府消灭 HCV 可能成为泰国更全面 HCV 治疗覆盖的典范。